Gilead Sciences, Inc.
CH ˙ SWX ˙ US3755581036
SecurityCH:GILD / Gilead Sciences, Inc.
InstitutionPensionmark Financial Group, Llc
Latest Disclosed Ownership30,121 shares
Latest Disclosed Value $ 4,197,977
Pensionmark Financial Group, Llc reports 5.14% decrease in ownership of GILD / Gilead Sciences, Inc.

On April 27, 2026 - Pensionmark Financial Group, Llc filed a 13F-HR form disclosing ownership of 30,121 shares of Gilead Sciences, Inc. (CH:GILD) valued at $4,197,977 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on March 13, 2026 disclosing 31,753 shares of Gilead Sciences, Inc.. This represents a change in shares of -5.14% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F GILEAD SCIENCES COM 375558103 30,121 -1,632 -5.14 4,198 7.70 0.0677
2026-03-13 2025-12-31 13F/A-1 GILEAD SCIENCES COM 375558103 31,753 3,589 12.74 3,897 24.66 0.0633
2026-02-04 2025-12-31 13F GILEAD SCIENCES COM 375558103 31,753 3,589 3,619 0.0692
2025-10-15 2025-09-30 13F GILEAD SCIENCES COM 375558103 28,164 1,053 3.88 3,126 4.03 0.0639
2025-08-04 2025-06-30 13F GILEAD SCIENCES COM 375558103 27,111 750 2.85 3,006 1.76 0.0682
2025-04-29 2025-03-31 13F GILEAD SCIENCES COM 375558103 26,361 1,874 7.65 2,954 30.61 0.0767
2025-02-12 2024-12-31 13F GILEAD SCIENCES COM 375558103 24,487 -1,512 -5.82 2,262 3.76 0.0619
2024-11-25 2024-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 25,999 6,535 33.57 2,180 63.22 0.0684
2024-11-14 2024-09-30 13F GILEAD SCIENCES COM 375558103 455,608 436,144 2,180 0.0683
2024-08-15 2024-06-30 13F GILEAD SCIENCES COM 375558103 19,464 19,464 1,335 0.0831
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.